For the purpose of this subchapter, the following shall be defined as follows:
PERSON. An individual, corporation, limited liability company, partnership, wholesaler, retailer, and any licensed or unlicensed business, including clerk, manager, or owner of a business.
SYNTHETIC CANNABINOID.
(1) Any substance within the following structural classes that displays binding activity at the CB1 and/or CB2 cannabinoid receptor sites. Binding activity may be documented in the following ways, including but not limited to:
(a) A patent or patent application or copy thereof that attests to the binding activity of the substance in question; and/or
(b) An article or document or copy thereof from a peer-reviewed scientific journal or equivalent publication that attests to the binding activity of the substance in question.
(2) Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with a substituent at the 5-position of the phenolic ring: whether or not substituted on the cyclohexyl ring to any extent.
(3) Any compound containing a 1-(1-naphthylmethyl)indene ring system with a substituent at the 3-position of the indene ring system: whether or not further substituted on the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent.
(4) Any compound containing an indole ring system with a substituent on the nitrogen atom and bearing an additional substituent at the 3-position of the indole ring system, with a linkage connecting the ring system to the substituent:
(a) Where the linkage connecting the indole ring system to the substituent at its 3 position is any of the following:
1. Alkyl.
2. Carbonyl.
3. Ester.
4. Thione.
5. Thioester.
6. Amino.
7. Alkylamino.
8. Amido.
9. Alkylamido.
(b) Where the substituent at the 3 position of the indole ring system is, disregarding the linkage, any of the following groups:
1. Naphthyl.
2. Quinolinyl.
3. Adamantyl.
4. Phenyl.
5. Cycloalkyl (limited to cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl).
6. Biphenyl.
7. Alkylamido (limited to ethylamido, propylamido, butanamido, or pentanamido).
(c) Whether or not the substituent at the 3 position of the indole ring system, disregarding the linkage, is further substituted to any extent.
(d) Whether or not further substituted on the indole ring system to any extent.
(5) Any compound containing an indazole ring system with a substituent at the 1-position nitrogen atom and bearing an additional substituent at the 3-position of the indazole ring system, with a linkage connecting the ring system to the substituent:
(a) Where the linkage connecting the indazole ring system to the substituent at its 3 position is any of the following:
1. Alkyl.
2. Carbonyl.
3. Ester.
4. Thione.
5. Thioester.
6. Amino.
7. Alkylamino.
8. Amido.
9. Alkylamido.
(b) Where the substituent at the 3 position of the indazole ring system is, disregarding the linkage, any of the following groups:
1. Naphthyl.
2. Quinolinyl.
3. Adamantyl.
4. Phenyl.
5. Cycloalkyl (limited to cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl).
6. Biphenyl.
7. Alkylamido (limited to ethylamido, propylamido, butanamido, or pentanamido).
(c) Whether or not the substituent at the 3 position of the indazole ring system, disregarding the linkage, is further substituted to any extent.
(d) Whether or not further substituted on the indazole ring system to any extent.
(6) Any compound containing a pyrrole ring with a substituent on the nitrogen atom and bearing an additional substituent at the 3-position of the pyrrole ring, with a linkage connecting the ring to the substituent:
(a) Where the linkage connecting the pyrrole ring to the substituent at its 3 position is any of the following:
1. Alkyl.
2. Carbonyl.
3. Ester.
4. Thione.
5. Thioester.
6. Amino.
7. Alkylamino.
8. Amido.
9. Alkylamido.
(b) Where the substituent at the 3 position of the pyrrole ring is, disregarding the linkage, any of the following groups:
1. Naphthyi.
2. Quinolinyl.
3. Adamantyl.
4. Phenyl.
5. Cycloalkyl (limited to cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl).
6. Biphenyl.
7. Alkylamido (limited to ethylamido, propylamido, butanamido, or pentanamido).
(c) Whether or not the substituent at the 3 position of the pyrrole ring, disregarding the linkage, is further substituted to any extent.
(d) Whether or not further substituted on the pyrrole ring to any extent.
(7) Any compound containing a pyrazole ring with a substituent at the 1-position nitrogen atom and bearing an additional substituent at the 3-position of the pyrazole ring with a linkage connecting the ring to the substituent:
(a) Where the linkage connecting the pyrazole ring to the substituent at its 3 position is any of the following:
1. Alkyl.
2. Carbonyl.
3. Ester.
4. Thione.
5. Thioester.
6. Amino.
7. Alkylamino.
8. Amido.
9. Alkylamido.
(b) Where the substituent at the 3 position of the pyrazole ring is, disregarding the linkage, any of the following groups:
1. Naphthyl.
2. Quinolinyl.
3. Adamantyl.
4. Phenyl.
5. Cycloalkyl (limited to cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl).
6. Biphenyl.
7. Alkylamido (limited to ethylamido, propylamido, butanamido, or pentanamido).
(c) Whether or not the substituent at the 3 position of the pyrazole ring, disregarding the linkage, is further substituted to any extent.
(d) Whether or not further substituted on the pyrazole ring to any extent.
(8) Includes, but is not limited to, the following:
(a) QUCHIC/BB-22.
(b) QUPIC/PB-22.
(c) 5-fluoro PB-22.
(d) STS-135.
(e) APICA/SDB-001.
(f) ADBICA.
(g) APINACA/AKB48.
(h) AB-FUBINACA.
(i) AB-PINACA.
(j) ADB-FUBINACA.
(k) AM-1248.
(l) AM-2233.
(m) AB-001.
(n) SDB-006.
(o) 5-chloro UR-144.
(9) This definition shall not include:
(a) Endocannabinoids that are naturally found in the human body;
(b) Delta-9 Tetrahydrocannabinol (THC) or other marijuana-derived cannabinoids, in the form of Marinol, Dronabinol, or another generic pharmaceutical equivalent; so long as the medication has been issued as the result of a valid prescription;
(c) Any other drugs that have cannabinoid receptor activity that are currently FDA-approved for medical use; or
(d) Marijuana and extracts of marijuana, as these are already controlled per NH R.S.A. 318:B.
(Ord. passed 10-7-14)